Our Mission Developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases. Experienced Leadership TeamMiles Suk CEO, Chairman Robert Markelewicz, MD Chief Medical Officer Experts on BoardsLaurie Glimcher, MD Former President and CEO, Dana-Farber Cancer Institute Ron Levy, MD Professor and Chief, Division of Oncology, Stanford School of Medicine George Tsokos, MD Professor of Medicine, Beth Israel Deaconess Medical Center Shiv Pillai, PhD Professor of Medicine, Harvard Medical School and Massachusetts General Hospital Steven Schnittman, MD, PhD Infectious Disease Specialist; Ex-NIH/Chief HIV Division; Ex-VP BMS Board of DirectorsMiles Suk Chairman Ian MacDonald Anthony D. Eisenberg Soo-Young Lee, Ph.D. Our Collaborators abprobio
